A--Chemical Screening and Optimization Facility

The National Institutes of Health is seeking a contractor to establish and operate a Chemical Screening and Optimization Facility (CSOF) under solicitation 75N94023R00008. The primary objective is to support the development of therapeutic indications related to contraception and reproductive health. Required services include the production of active recombinant proteins, assay development, chemical screening, and the identification and optimization of chemical lead series. The facility must also possess the capacity to produce milligram to kilogram quantities of materials for both in vitro and in vivo testing.

This requirement is classified under NAICS 541715 for Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) and PSC AN11 for Health R&D Services; Health Care Services; Basic Research. There is no set-aside designated for this procurement. The solicitation was published on March 31, 2023, and underwent updates through May 31, 2023, with Adelola O. St. John serving as the point of contact.

Prospective offerors must submit their responses by the deadline of June 8, 2023. The solicitation documentation includes two primary attachments: Sol_75N94023R00008.pdf and Chemical_Optimization_Screening_Facility_RFP.pdf, both of which were issued on April 21, 2023. Details regarding the specific place of performance and the duration of the contract period are contained within the formal solicitation materials.